See more : Cumulus Media Inc. (CMLS) Income Statement Analysis – Financial Results
Complete financial analysis of TransGlobal Assets Inc. (TMSH) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of TransGlobal Assets Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- Modern Times Group MTG AB (publ) (MTG-B.ST) Income Statement Analysis – Financial Results
- Robex Resources Inc. (RBX.V) Income Statement Analysis – Financial Results
- Oxford Metrics plc (OMG.L) Income Statement Analysis – Financial Results
- Reka Industrial Oyj (REKA.HE) Income Statement Analysis – Financial Results
- Axcella Health Inc. (AXLA) Income Statement Analysis – Financial Results
TransGlobal Assets Inc. (TMSH)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: http://www.transglobalassets.com
About TransGlobal Assets Inc.
TransGlobal Assets Inc., together with its subsidiaries, distributes motor vehicle fuel and tobacco products to retail outlets in the State of Oregon. The company was formerly known as TimeShare Holdings Inc. and changed its name to TransGlobal Assets Inc. in March 2011. TransGlobal Assets Inc. was founded in 2005 and is based in Cheyenne, Wyoming.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 | 2015 | 2014 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 212.81K | 0.00 | 0.00 | 101.27K | 1.00K | 0.00 | 0.00 | 0.00 | 1.76M | 122.60K | 20.00K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 41.81K | 0.00 | 0.00 | 31.72K | 417.00 | 0.00 | 0.00 | 0.00 | 1.50M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 171.00K | 0.00 | 0.00 | 69.55K | 583.00 | 0.00 | 0.00 | 0.00 | 256.78K | 122.60K | 20.00K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 80.35% | 0.00% | 0.00% | 68.68% | 58.30% | 0.00% | 0.00% | 0.00% | 14.58% | 100.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 508.00 | 0.00 | 0.00 | 12.19K | 4.38K | 41.90K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 662.25K | 6.18K | 8.64K | 499.00K | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 169.09K | 291.88K | 403.35K | 495.54K | 22.13K | 201.20K | 177.98K | 138.18K | 254.65K | 662.25K | 6.18K | 8.64K | 499.00K | 389.05K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 169.59K | 291.88K | 403.35K | 507.73K | 26.51K | 243.10K | 177.98K | 138.18K | 254.65K | 662.25K | 6.18K | 8.64K | 499.00K | 389.05K |
| Cost & Expenses | 211.40K | 291.88K | 403.35K | 539.45K | 26.92K | 243.10K | 177.98K | 138.18K | 1.76M | 662.25K | 6.18K | 8.64K | 499.00K | 389.05K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 111.63K | 69.97K | 112.57K | 18.71K | 1.82K | 24.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.73K | 34.46K | 27.31K |
| Depreciation & Amortization | 167.90K | 228.49K | 236.56K | 206.30K | 171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.60K | 3.60K | 3.60K | 3.62K |
| EBITDA | 1.40K | -291.88K | -403.34K | -438.19K | 127.45K | -243.10K | -177.98K | -138.18K | 2.13K | -539.65K | 17.42K | -5.04K | -495.40K | -399.28K |
| EBITDA Ratio | 0.66% | 0.00% | 0.00% | -432.71% | -2,592.00% | 0.00% | 0.00% | 0.00% | 0.12% | -440.16% | 87.10% | 0.00% | 0.00% | 0.00% |
| Operating Income | 1.40K | -291.88K | -403.34K | -438.19K | -25.92K | -243.10K | -177.98K | -138.18K | 2.13K | -539.65K | 13.82K | -8.64K | -499.00K | -389.05K |
| Operating Income Ratio | 0.66% | 0.00% | 0.00% | -432.71% | -2,592.00% | 0.00% | 0.00% | 0.00% | 0.12% | -440.16% | 69.10% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -111.62K | -69.97K | -112.58K | -18.70K | 151.55K | -24.00 | 3.00 | 5.00 | 0.00 | 539.65K | 0.00 | -40.73K | 27.78K | -13.46K |
| Income Before Tax | -110.22K | -361.85K | -515.92K | -456.89K | 125.63K | -243.13K | -177.98K | -138.18K | 2.13K | 0.00 | 0.00 | -49.37K | -471.22K | -402.51K |
| Income Before Tax Ratio | -51.80% | 0.00% | 0.00% | -451.18% | 12,562.70% | 0.00% | 0.00% | 0.00% | 0.12% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -167.90K | -228.49K | -236.56K | -206.30K | -171.86K | 0.00 | 0.00 | 0.00 | 0.00 | 539.65K | 0.00 | 0.00 | 34.46K | 13.46K |
| Net Income | -110.22K | -361.85K | -515.92K | -456.89K | 125.63K | -243.13K | -177.98K | -138.18K | 2.13K | -539.65K | 13.82K | -49.37K | -471.22K | -402.51K |
| Net Income Ratio | -51.80% | 0.00% | 0.00% | -451.18% | 12,562.70% | 0.00% | 0.00% | 0.00% | 0.12% | -440.16% | 69.10% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -0.02 | -0.01 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | -0.02 | -0.01 |
| Weighted Avg Shares Out | 867.33M | 362.10M | 300.10M | 212.87M | 212.87M | 212.87M | 212.87M | 212.87M | 212.87M | 102.59M | 82.52M | 30.52M | 30.17M | 30.11M |
| Weighted Avg Shares Out (Dil) | 867.33M | 362.10M | 300.10M | 212.87M | 212.87M | 212.87M | 212.87M | 212.87M | 212.87M | 102.59M | 82.52M | 30.52M | 30.17M | 30.11M |
TransGlobal Assets Inc. provides an update with the Joint-Venture partner Better Health Sciences For Pets Corp.
CHEYENNE, Wyo., April 18, 2024 (GLOBE NEWSWIRE) -- TransGlobal Assets Inc.'s (OTC: TMSH) joint-venture partner, Better Health Sciences For Pets Corp., has taken a significant step by submitting two additional products to Health Canada for approval as Veterinary Health Products...
TransGlobal Assets Inc. provides an update with the Joint-Venture partner Better Health Sciences For Pets Corp.
Cheyenne, WY, April 18, 2024 – TransGlobal Assets Inc. (OTC: TMSH) joint-venture partner, Better Health Sciences For Pets Corp., has taken a significant step by submitting two additional products to Health Canada for approval as Veterinary Health Products (VHPs).
TMSH provides a corporate update for fiscal 2024
Cheyenne, WY, April 03, 2024 – TransGlobal Assets Inc. (OTC: TMSH) is making significant strides in various sectors, particularly in the medical wellness, health, and pet industries. Here is a corporate update for fiscal 2024.
TransGlobal Assets Inc. Ventures into Pet Health Industry through Strategic Joint Venture
Cheyenne, WY, March 21, 2024 – TransGlobal Assets Inc. (OTC: TMSH) is excited to announce a significant milestone as its wholly owned subsidiary, Better Health Sciences Inc., has entered into a Joint Venture Agreement with Better Health Sciences For Pets...
TransGlobal Assets Inc. Ventures into Pet Health Industry through Strategic Joint Venture
CHEYENNE, Wyo., March 21, 2024 (GLOBE NEWSWIRE) -- TransGlobal Assets Inc. (OTC: TMSH) is excited to announce a significant milestone as its wholly owned subsidiary, Better Health Sciences Inc., has entered into a Joint Venture Agreement with Better Health Sciences...
PRISM MediaWire – Weekly Press Resume – Oct. 23 to Oct. 27, 2023
New York, New York, October 27, 2023 PRISM MediaWire – Weekly Press Resume Oct. 23 to Oct. 27, 2023 Lipella Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference Metatron Partners with MML Marketing, Boasting a Proven Track Record...
TransGlobal Assets Inc. (OTC: TMSH) Wholly Owned Subsidiary, Better Health Sciences Inc., Signs an Exclusive Joint-Venture with Canna-King
Ann Arbor, Michigan, October 24, 2023 – TransGlobal Assets Inc. (OTC: TMSH) a holdings company whose subsidiaries specialize in offering advanced products and services and assist patients in obtaining their medical licenses to produce and/or obtain medical cannabis from licensed...
TransGlobal Assets Inc. (OTC: TMSH) Wholly Owned Subsidiary, Better Health Sciences Inc., Acquires the Assets of Synergy Health Services Inc.
Ann Arbor, Michigan, September 26, 2023 – TransGlobal Assets Inc. (OTC: TMSH) is pleased to announce that, pursuant to an Acquisition Agreement, its wholly owned subsidiary Better Health Sciences, Inc., has acquired 100% of the assets of Synergy Health Services...
TransGlobal Assets Inc. (TMSH) Hires Architectural Firm For Its Hemp Ranch Development Project
Pittsburgh, PA, October 19, 2021 – McapMediaWire – TransGlobal Assets Inc. (OTC Pink: TMSH) is pleased to announce that it has selected a Michigan-based Architectural Firm, Steiner Associates, for its Hemp Ranch development project. The firm is located in Livonia,...
TransGlobal Assets Inc. (TMSH) Hires Architectural Firm For Its Hemp Ranch Development Project
Pittsburgh, PA, Oct. 19, 2021 (GLOBE NEWSWIRE) -- TransGlobal Assets Inc. (OTC Pink: TMSH) is pleased to announce that it has selected a Michigan-based Architectural Firm, Steiner Associates, for its Hemp Ranch development project. The firm is located in Livonia,...
Source: https://incomestatements.info
Category: Stock Reports